Robert Leclair v. James Dzurenda

CourtCourt of Appeals for the Ninth Circuit
DecidedApril 3, 2025
Docket23-15334
StatusUnpublished

This text of Robert Leclair v. James Dzurenda (Robert Leclair v. James Dzurenda) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Robert Leclair v. James Dzurenda, (9th Cir. 2025).

Opinion

NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS APR 3 2025 MOLLY C. DWYER, CLERK U.S. COURT OF APPEALS FOR THE NINTH CIRCUIT

ROBERT LECLAIR, No. 23-15334

Plaintiff-Appellee, D.C. No. 3:19-cv-00404-MMD-CLB v.

JAMES DZURENDA; et al., MEMORANDUM*

Defendants-Appellants,

and

CHARLES DANIELS; HAROLD WICKHAM,

Defendants.

Appeal from the United States District Court for the District of Nevada Miranda M. Du, Chief District Judge, Presiding

Submitted April 1, 2025** San Francisco, California

Before: HURWITZ, KOH, and JOHNSTONE, Circuit Judges.

* This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. ** The panel unanimously concludes this case is suitable for decision without oral argument. See Fed. R. App. P. 34(a)(2). Robert LeClair, a Nevada state prisoner, claims in this 42 U.S.C. § 1983 action

that Nevada Department of Corrections (“NDOC”) employees (collectively

“Defendants”) violated the Eighth Amendment by denying him Hepatitis C (“Hep-

C”) treatment pursuant to NDOC Medical Directive 219 (“MD 219”). The district

court denied the Defendants’ motion for summary judgment, finding that they were

not entitled to qualified immunity. Exercising jurisdiction over the appeal of the

denial of summary judgment under 28 U.S.C. § 1291 and the collateral order

doctrine, see Andrews v. City of Henderson, 35 F.4th 710, 715 (9th Cir. 2022), and

reviewing de novo, see Carley v. Aranas, 103 F.4th 653, 659 (9th Cir. 2024), we

reverse and remand.

“Prison officials violate the Eighth Amendment if they are deliberately

indifferent to a prisoner’s serious medical needs.” Peralta v. Dillard, 744 F.3d 1076,

1081 (9th Cir. 2014) (en banc) (cleaned up). “Section 1983 . . . provides a cause of

action in tort” for such violations. Carley, 103 F.4th at 659. Prison officials,

however, may assert qualified immunity as a defense in a § 1983 deliberate

indifference suit. See, e.g., id. at 659. Determining whether the officials are entitled

to qualified immunity potentially involves “two questions: (1) whether the official’s

conduct violated a constitutional right; and (2) whether that right was clearly

established at the time of the violation.” Id. at 659 (cleaned up). But if the answer to

the second question is “no,” officials are protected by qualified immunity even if

2 there is a constitutional violation. See id. “For a right to be clearly established, it

must be ‘sufficiently clear that every reasonable official would have understood that

what he is doing violates that right.’” Id. at 660 (quoting Rivas-Villegas v.

Cortesluna, 595 U.S. 1, 5 (20221) (per curiam)). We have discretion to determine

the order in which these inquiries are addressed. See Pearson v. Callahan, 555 U.S.

223, 236 (2009).

LeClair claims that Defendants “acted with deliberate indifference to” his

“serious medical needs by developing and implementing MD 219.” The Defendants

are therefore entitled to qualified immunity unless it was clearly established between

2012 and November 2019, the period during which LeClair was denied Hep-C

treatment, that MD-219 violated the Eighth Amendment.1

We recently held that it was not clearly established by May 2018 that denying

a Nevada state prisoner Hep-C treatment under MD 219 constituted deliberate

indifference. See Carley, 103 F.4th at 661-62. LeClair does not contend that the law

became clearly established to the contrary between May 2018 and November 2019.

Because “no decision of the Supreme Court, our court, or a consensus of courts

1 Under a September 2019 revision to MD 219, LeClair became eligible for treatment, which he began in November 2019. In October 2020, NDOC entered into a consent decree providing that all prisoners testing positive for Hep-C will receive treatment. See In re HCV Prison Litig., No. 19-cv-00577, 2020 WL 6363842 (D. Nev. Oct. 29, 2020).

3 would have put [the Defendants] on notice that treatment prioritization schemes like

MD 219 violated the Eighth Amendment” during the relevant period, id. at 662-63

(cleaned up), the Defendants were entitled to qualified immunity, even assuming

that MD 219 is unconstitutional. The district court therefore should have granted the

Defendants’ motion for summary judgment. We reverse its order denying summary

judgment and remand with instructions to grant the Defendants’ motion.

REVERSED AND REMANDED.2

2 Defendants’ request for judicial notice, Dkt. 24, is granted.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Pearson v. Callahan
555 U.S. 223 (Supreme Court, 2009)
Cion Peralta v. T. Dillard
744 F.3d 1076 (Ninth Circuit, 2014)
Rivas-Villegas v. Cortesluna
595 U.S. 1 (Supreme Court, 2021)
Daniel Andrews v. City of Henderson
35 F.4th 710 (Ninth Circuit, 2022)
Elizabeth Carley v. Romeo Aranas
103 F.4th 653 (Ninth Circuit, 2024)

Cite This Page — Counsel Stack

Bluebook (online)
Robert Leclair v. James Dzurenda, Counsel Stack Legal Research, https://law.counselstack.com/opinion/robert-leclair-v-james-dzurenda-ca9-2025.